If you combined all the bullish arguments for Iqiyi (NASDAQ:IQ), the most commonly cited theme will likely be that the company is the Netflix (NASDAQ:NFLX) of China. And because China is more than four times larger than the U.S. population-wise, IQ stock represents untapped potential. Source: natmac stock / Shutterstock.com Further, because the Chinese government
It’s been a hard year for marijuana firms and their investors. The industry has been wracked with worries about health concerns, waning demand and regulatory tie-ups. Naturally, this has taken a toll on marijuana stock prices. Aurora Cannabis (NYSE:ACB) is a prime example of a pot stock that’s been hammered over the past 12 months.
Back during Sony’s (NYSE:SNE) tough days, I personally witnessed the dramatic rise and influence of GoPro (NASDAQ:GPRO). At the time, I was a senior business analyst tasked with increasing Sony’s digital camera market share. From a product perspective, GPRO had the better ideas. But I’m glad I invested in SNE rather than GoPro stock. Source:
Nio (NYSE:NIO) stock climbed more than 11% after the “Tesla (NASDAQ:TSLA) of China” reported strong third-quarter earnings on Oct. 8. Investors were especially pleased to learn that the company’s vehicle delivery increased by 35% from the second quarter. Source: Carrie Fereday / Shutterstock.com This news came at just the right time for Nio stock, since
Morgan Stanley equity strategist Michael Wilson suggested Oct. 14 that the mini-trade deal with China announced by Donald Trump the previous week is not going to help stocks reverse their course and move higher despite the two-day rally on the news. “The bottom line is that without a significant roll-back of existing tariffs, we don’t
Last October, Aurora Cannabis (NYSE:ACB) went public on the New York Stock Exchange. At the time, investors were full of optimism about the Canadian pot stock. The company beat out its rivals in terms of production capacity and was already expanding globally. But nearly a year later, ACB stock’s prospects don’t seem quite as strong.
In a good economy, restaurant stocks are usually good bets. And there are some in this sector that are doing very well and are worth considering. I wrote about one in particular last week. But a rising tide doesn’t lift all boats. And some restaurant stocks are having a tough go of it now. Consumer
Tilray (NASDAQ:TLRY) has dropped more than 55% in the past two months since August 13 and over 61% in the past six months since April 26. In short, the jig is up. The market is not going to put up with Tilray stock as it remains unprofitable. Source: Jarretera / Shutterstock.com The fact that TLRY
With many of the major financial institutions posting strong numbers for the third quarter, bank stocks appear poised as the investment class to jump into. Recent fundamentals, such as a temporary thaw in the U.S.-China trade war, gives credence to this argument. However, I’m going to take a contrarian approach, suggesting that they’re instead stocks
Shares of leading inbound marketing software company HubSpot (NASDAQ:HUBS) have been on fire for a long time. Over the past three years, as HubSpot has grown revenues at a 35%-plus compounded annual growth rate and expanded operating margins by more than 1,000 basis points, HUBS stock has rattled off a 200%-plus gain. At this point,
Theoretically, it was the news that Wall Street was anxiously seeking. After a protracted trade war between the U.S. and China that left neither side as the clear victor, investors were ready to move forward with a productive relationship. Of course, one of the biggest beneficiaries would be China-based investments, such as JD.com (NASDAQ:JD) and
For just a moment, in the summer, it seemed that Lyft (NASDAQ:LYFT) was going to give its first public investors a profit. On July 19 it closed at $67.45, buoyed by favorable moral comparisons with rival Uber (NYSE:UBER). Source: Tero Vesalainen / Shutterstock.com But its results for the June quarter showed no reason for optimism.
It may sound like a familiar refrain, and it is, but cannabis equities are imperiled at the moment and Aurora Cannabis (NYSE:ACB) stock is not immune to that theme. Last week, shares of the Canadian medical marijuana grower plunged 16.36%, extending the stock’s 12-month loss to over 63%. Some that tumble is attributable to Hexo (NYSE:HEXO),